Literature DB >> 19780025

Mutations in the external loops of BK virus VP1 and urine viral load in renal transplant recipients.

Sara Tremolada1, Serena Delbue, Lorenzo Castagnoli, Sara Allegrini, Umberto Miglio, Renzo Boldorini, Francesca Elia, Jennifer Gordon, Pasquale Ferrante.   

Abstract

Polyomavirus-associated nephropathy (PVAN) is a major complication that occurs after renal transplantation and is induced by reactivation of the human polyomavirus BK (BKV). The structure of the viral capsid protein 1 (VP1) is characterized by the presence of external loops, BC, DE, EF, GH, and HI, which are involved in receptor binding. The pathogenesis of PVAN is not well understood, but viral risk factors are thought to play a crucial role in the onset of this pathology. In an attempt to better understand PVAN pathogenesis, the BKV-VP1 coding region was amplified, cloned, and sequenced from the urine of kidney transplant recipients who did, and did not, develop the pathology. Urine viral loads were determined by using real time quantitative PCR (Q-PCR). Amino acid substitutions were detected in 6/8 patients, and 6/7 controls. The BC and EF loop regions were most frequently affected by mutations, while no mutations were found within the GH and HI loops of both patients and controls. Some mutations, that were exclusively detected in the urine of PVAN patients, overlapped with previously reported mutations, although a correlation between changes in amino acids and the development of PVAN was not found. Urine viral loads were higher than that of the proposed cut-off loads for identification of patients that are at a high risk of developing PVAN (10(7) copies/ml), both in the PVAN and control groups, thus confirming that urine viral load is not a useful predictive marker for the development of PVAN.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19780025      PMCID: PMC2783606          DOI: 10.1002/jcp.21937

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  40 in total

1.  Nephropathy due to polyomavirus type BK.

Authors:  P S Randhawa; A J Demetris
Journal:  N Engl J Med       Date:  2000-05-04       Impact factor: 91.245

2.  Relationships between BK virus lineages and human populations.

Authors:  Huai-Ying Zheng; Yuriko Nishimoto; Qin Chen; Masami Hasegawa; Shan Zhong; Hiroshi Ikegaya; Norikazu Ohno; Chie Sugimoto; Tomokazu Takasaka; Tadaichi Kitamura; Yoshiaki Yogo
Journal:  Microbes Infect       Date:  2006-12-08       Impact factor: 2.700

3.  Genetic variability in BK Virus regulatory regions in urine and kidney biopsies from renal-transplant patients.

Authors:  Gunn-Hege Olsen; Per Arne Andresen; Hilde Tveitan Hilmarsen; Ola Bjørang; Helge Scott; Karsten Midtvedt; Christine H Rinaldo
Journal:  J Med Virol       Date:  2006-03       Impact factor: 2.327

4.  Evolution of BK virus based on complete genome data.

Authors:  Yuriko Nishimoto; Tomokazu Takasaka; Masami Hasegawa; Huai-Ying Zheng; Qin Chen; Chie Sugimoto; Tadaichi Kitamura; Yoshiaki Yogo
Journal:  J Mol Evol       Date:  2006-07-28       Impact factor: 2.395

Review 5.  BK-virus nephropathy in renal transplants-tubular necrosis, MHC-class II expression and rejection in a puzzling game.

Authors:  V Nickeleit; H H Hirsch; M Zeiler; F Gudat; O Prince; G Thiel; M J Mihatsch
Journal:  Nephrol Dial Transplant       Date:  2000-03       Impact factor: 5.992

6.  A regulatory region rearranged BK virus is associated with tubulointerstitial nephritis in a rejected renal allograft.

Authors:  C H Chen; M C Wen; M Wang; J D Lian; M J Wu; C H Cheng; K H Shu; D Chang
Journal:  J Med Virol       Date:  2001-05       Impact factor: 2.327

7.  Mutations in the BC-loop of the BKV VP1 region do not influence viral load in renal transplant patients.

Authors:  Ellen Krautkrämer; Theresa M Klein; C Sommerer; Paul Schnitzler; Martin Zeier
Journal:  J Med Virol       Date:  2009-01       Impact factor: 2.327

8.  Identification of amino acid residues in BK virus VP1 that are critical for viability and growth.

Authors:  Aisling S Dugan; Megan L Gasparovic; Natia Tsomaia; Dale F Mierke; Bethany A O'Hara; Kate Manley; Walter J Atwood
Journal:  J Virol       Date:  2007-08-15       Impact factor: 5.103

9.  Even distribution of BK polyomavirus subtypes and subgroups in the Japanese Archipelago.

Authors:  S Zhong; Y Yogo; Y Ogawa; Y Oshiro; K Fujimoto; T Kunitake; H-Y Zheng; A Shibuya; T Kitamura
Journal:  Arch Virol       Date:  2007-06-01       Impact factor: 2.574

10.  Polyomavirus BK with rearranged noncoding control region emerge in vivo in renal transplant patients and increase viral replication and cytopathology.

Authors:  Rainer Gosert; Christine H Rinaldo; Georg A Funk; Adrian Egli; Emilio Ramos; Cinthia B Drachenberg; Hans H Hirsch
Journal:  J Exp Med       Date:  2008-03-17       Impact factor: 14.307

View more
  16 in total

1.  Molecular characterization of BK virus in patients infected with human immunodeficiency virus.

Authors:  Danijela Karalic; Ivana Lazarevic; Ana Banko; Maja Cupic; Djordje Jevtovic; Tanja Jovanovic
Journal:  Med Microbiol Immunol       Date:  2015-10-26       Impact factor: 3.402

2.  Early identification of renal transplant recipients with high risk of polyomavirus-associated nephropathy.

Authors:  K Teutsch; F Schweitzer; E Knops; R Kaiser; H Pfister; J Verheyen; H Göbel; T Cingöz; V Di Cristanziano
Journal:  Med Microbiol Immunol       Date:  2015-03-07       Impact factor: 3.402

Review 3.  Management of polyomavirus-associated nephropathy in renal transplant recipients.

Authors:  Dirk R J Kuypers
Journal:  Nat Rev Nephrol       Date:  2012-04-17       Impact factor: 28.314

4.  Evidence supporting the association of polyomavirus BK genome with prostate cancer.

Authors:  Serena Delbue; Deliu-Victor Matei; Camilla Carloni; Valentina Pecchenini; Silvia Carluccio; Sonia Villani; Valeria Tringali; Antonio Brescia; Pasquale Ferrante
Journal:  Med Microbiol Immunol       Date:  2013-07-03       Impact factor: 3.402

Review 5.  Intra-patient viral evolution in polyomavirus-related diseases.

Authors:  Dorian McIlroy; Franck Halary; Céline Bressollette-Bodin
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-05-27       Impact factor: 6.237

6.  Limited Variation in BK Virus T-Cell Epitopes Revealed by Next-Generation Sequencing.

Authors:  Malaya K Sahoo; Susanna K Tan; Sharon F Chen; Beatrix Kapusinszky; Katherine R Concepcion; Lynn Kjelson; Kalyan Mallempati; Heidi M Farina; Marcelo Fernández-Viña; Dolly Tyan; Paul C Grimm; Matthew W Anderson; Waldo Concepcion; Benjamin A Pinsky
Journal:  J Clin Microbiol       Date:  2015-07-22       Impact factor: 5.948

7.  Polymorphisms of the BK virus subtypes and their influence on viral in vitro growth efficiency.

Authors:  Sara Tremolada; Serena Delbue; Sara Larocca; Camilla Carloni; Francesca Elia; Kamel Khalili; Jennifer Gordon; Pasquale Ferrante
Journal:  Virus Res       Date:  2010-02-04       Impact factor: 3.303

8.  JC virus urinary excretion and seroprevalence in natalizumab-treated multiple sclerosis patients.

Authors:  Serena Delbue; Francesca Elia; Camilla Carloni; Valentina Pecchenini; Diego Franciotta; Matteo Gastaldi; Elena Colombo; Lucia Signorini; Silvia Carluccio; Anna Bellizzi; Roberto Bergamaschi; Pasquale Ferrante
Journal:  J Neurovirol       Date:  2014-07-23       Impact factor: 2.643

9.  Characterization of BK Polyomaviruses from Kidney Transplant Recipients Suggests a Role for APOBEC3 in Driving In-Host Virus Evolution.

Authors:  Alberto Peretti; Eileen M Geoghegan; Diana V Pastrana; Sigrun Smola; Pascal Feld; Marlies Sauter; Stefan Lohse; Mayur Ramesh; Efrem S Lim; David Wang; Cinzia Borgogna; Peter C FitzGerald; Valery Bliskovsky; Gabriel J Starrett; Emily K Law; Reuben S Harris; J Keith Killian; Jack Zhu; Marbin Pineda; Paul S Meltzer; Renzo Boldorini; Marisa Gariglio; Christopher B Buck
Journal:  Cell Host Microbe       Date:  2018-05-09       Impact factor: 21.023

10.  Human polyomaviruses identification by logic mining techniques.

Authors:  Emanuel Weitschek; Alessandra Lo Presti; Guido Drovandi; Giovanni Felici; Massimo Ciccozzi; Marco Ciotti; Paola Bertolazzi
Journal:  Virol J       Date:  2012-03-02       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.